Yan-Yan Mo

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM To investigate clinical outcomes of chronic hepatitis B (CHB) and liver cirrhosis (LC) patients under whole-course management with lamivudine (LAM). METHODS This was a retrospective-prospective cohort study based on two nonrandom cohorts of Chinese patients (LAM group and history control group). Two hundred thirty-eight patients with LAM treatment for(More)
  • 1